FIRM FIXED PRICENO SET ASIDE USED.

CLARIVATE ANALYTICS (US) LLC - CLARIVATE ANALYTICS US LLC R&D FOR DEVELOPING MCMS FOR CHEMICAL THREATS USING DRUG REPOSITIONING (AOI #5 REDIRECT)

PIID: 75A50121C00031Solicitation ID: BAA-20-100-SOL-0002

Signed Date: Nov 7, 2025Effective Date: Sep 20, 2021End Date: Closed on Feb 28, 2023

Award $

$749K

Vendor

CLARIVATE ANALYTICS (US) LLC

NAICS

541714

Signed Date

Nov 7, 2025

Key Details

Dollars Obligated

$749,201

Base & All Options

Awarding Agency

Awarding Sub-Agency

Office of Assistant Secretary for Preparedness and Response

NAICS Code

Product Service Code

AN15 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

999

Place of Performance

ALEXANDRIA, VA, 223143359, CD-VA-08

CLARIVATE ANALYTICS US LLC R&D FOR DEVELOPING MCMS FOR CHEMICAL THREATS USING DRUG REPOSITIONING (AOI #5 REDIRECT)

On Nov 7, 2025, Department of Health and Human Services obligated $749,201 to CLARIVATE ANALYTICS (US) LLC for clarivate analytics us llc r&d for developing mcms for chemical threats using drug repositioning (aoi #5 redirect). The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 999 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in ALEXANDRIA, VA.